Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1902941

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1902941

Continuous Glucose Monitoring Devices Market Size, Share, and Growth Analysis, By Component (Transmitters, Sensors), By Connectivity (Bluetooth, 4G), By End-use, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Continuous Glucose Monitoring Devices Market size was valued at USD 9.84 Billion in 2024 and is poised to grow from USD 11.17 Billion in 2025 to USD 30.76 Billion by 2033, growing at a CAGR of 13.5% during the forecast period (2026-2033).

The rising prevalence of diabetes, coupled with the increasing adoption of continuous glucose monitoring (CGM) devices, is driving substantial market growth. With millions affected globally, CGM devices are becoming essential tools for managing diabetes, providing critical insights into dietary habits, medication adherence, physical activity, and overall health. The development of digital therapeutic solutions has enhanced connectivity between manufacturers and patients, fostering a more integrated approach to diabetes management. Numerous applications are now available, effectively leveraging CGM data to identify trends and advise on lifestyle modifications. These innovative features not only empower patients in their health journeys but also significantly contribute to the positive growth trajectory of the CGM device market, highlighting its expanding role in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising global incidence of diabetes serves as a major catalyst for the demand for effective monitoring and management tools, such as continuous glucose monitoring devices. As more individuals are diagnosed with this chronic condition, the need for reliable, real-time tracking of glucose levels has become paramount. These devices offer patients enhanced control over their health by allowing for timely adjustments to their treatment plans, thereby improving overall diabetes management. The emphasis on better health outcomes and quality of life further propels the growth of this market, as individuals seek innovative solutions to maintain optimal glucose levels and prevent complications associated with diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite the advancements in accuracy of continuous glucose monitoring devices, there remain instances where these devices may show occasional inconsistencies when contrasted with conventional blood glucose testing methods. This variability can lead to apprehensions among users regarding the reliability of the readings, impacting their trust and overall acceptance of the technology. As a result, some individuals may prefer to rely on traditional methods, especially in critical situations where precise glucose levels are imperative for health management. This hesitation to fully embrace continuous monitoring could hinder the broader adoption of these innovative devices within the market.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) devices market is witnessing a robust trend towards integration with digital health platforms, enhancing user experience and data management. This convergence enables individuals to effortlessly monitor their glucose levels alongside additional health metrics, promoting a more holistic approach to personal health management. As demand for technology-driven health solutions rises, CGM devices are evolving into sophisticated tools that offer real-time data insights, facilitating proactive lifestyle adjustments and improved diabetes management. This trend reflects a broader shift towards interconnected healthcare systems, where data synergy supports users in making informed health decisions and achieving better health outcomes.

Product Code: SQMIG35A2568

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis
  • Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2026-2033)

  • Market Overview
  • Transmitters
  • Sensors
  • Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2026-2033)

  • Market Overview
  • Bluetooth
  • 4G
  • Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2026-2033)

  • North America (Component, Connectivity, End-use)
    • US
    • Canada
  • Europe (Component, Connectivity, End-use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Connectivity, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Connectivity, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Connectivity, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Senseonics Holdings, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlySens Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tandem Diabetes Care, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care Holdings AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Menarini Diagnostics (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nemaura Medical Inc. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medisana GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arkray, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroTech Medical (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!